Category Archives: Uncategorized

Mark Wainberg, 1945-2017

By on .

The HIV community lost a leader and a champion with the death of Dr. Mark Wainberg Tuesday. The chair of the HIV Medicine Association, a producer of this blog, released a statement recognizing some of Dr. Wainberg’s contributions today, which we share here: The HIV community is deeply saddened to learn of the tragic loss […]

Researchers find 20 times the rate of specific neurological birth defects in pregnancies with laboratory-indicated Zika infection than found in surveillance programs prior to Zika’s arrival

By on .

In 2013 and 2014, three programs tracking birth defects — in Massachusetts, North Carolina and metropolitan Atlanta —  recorded 747 infants and fetuses with microcephaly and or other abnormalities of the central nervous system and eyes — about three in every 1,000 births. That was during what the U.S. Centers for Disease Control and Prevention […]

WHO prioritizes need for new antibiotics with list of bacteria posing greatest threats

By on .

In the latest in a series of moves responding to the global health threats posed by spread of antibiotic-resistant bacteria, the World Health Organization today released a list of “priority pathogens” calling for urgent and strongly supported research and development of new medicines to target the most dangerous among them. Guiding selection of bacteria making […]

What we’re reading: Making the case for, maintaining the impact of U.S. global health leadership – abroad and at home

By on .

The Vital Case for Global Health Investments by the United States Government – The cost effectiveness of controlling infectious disease outbreaks where they begin, the protection that improving health capacities globally offers American travelers and guest workers, the common good advanced by global health research, and the good will generated by humane international responses are […]

115th Congress and Global Health: House Energy and Commerce gets new Chair, new leader and members for its Health Subcommittee

By on .

Rep. Greg Walden (R-OR) – Fresh after ensuring the House remained in Republican control after serving as chair of the National Republican Congressional Committee, Rep. Walden takes over as chairman of the House Energy and Commerce Committee from Rep. Fred Upton, who stepped down due to term limits. Before he was elected to the House […]

Global burden of disease report shows gains made from HIV response, work that remains to respond to infectious disease

By on .

Global life expectancy has increased by 10.2 years since 1980, with the most marked increases occurring over the past decade in Sub-Saharan Africa, where the expansion of antiretroviral therapy and prevention of mother-to-child transmission of HIV activities have expanded life expectancy by more than ten years in countries with the highest HIV burdens. Zimbabwe in […]

A commitment without a target, a shifting landscape, dollars in diagnostics . . . We’re reading about antimicrobial resistance and baby steps

By on .

UN declaration on antimicrobial resistance lacks targets – While the 700,000 people who die of drug-resistant infections worldwide annually could increase to 10 million without concerted and collaborative action over the next few decades, the commitment finalized at the recent United Nations High-Level meeting to address the problem doesn’t ask much of the nations signing […]

Antimicrobial resistance takes center stage

By on .

Forum explores global and diverse causes, challenges, impacts, of dwindling treatments for infectious diseases NEW YORK — On the eve of the first gathering of world leaders confronting the worldwide and growing threat of infections resistant to existing medicines, Professor Ramanan Laxminarayan of the Center for Disease Dynamics, Economics & Policy emphasized the opportunity the moment […]

UN access to medicines panel seeks to reconcile business of health with right to health

By on .

A United Nations panel’s report released last week examining barriers between medicines and the people who need them traces the divergence of two paths over the previous century: one towards a recognition of human rights to health, and the other toward industries’ rights to profit from their innovations. The results of those divergent paths, the […]